Anti-RIPK2 Antibody (A97287)

Name: Anti-RIPK2 Antibody
Brand: Antibodies.com
SKU: A97287
Price: 115.0 GBP
Availability: InStock

Enlarge Image

This product is discontinued

Anti-RIPK2 Antibody (A97287) has been discontinued and is no longer available.

View all RIP2 Antibodies.

Specifications

Name

Anti-RIPK2 Antibody

Description

Rabbit polyclonal antibody to RIPK2.

Applications

WB, IHC, ELISA

Dilutions

WB: 1:500~1:1000, IHC: 1:50~1:100, ELISA: 1:40000

Reactivity

Human, Mouse

Immunogen

Synthetic peptide derived from human RIPK2 (amino acids 146-195).

Host

Rabbit

Clonality

Polyclonal

Isotype

IgG

Conjugate

Unconjugated

Purification

Purified from rabbit serum by antigen affinity chromatography using the immunizing peptide.

Molecular Weight

61kDa

Product Form

Liquid

Formulation

Supplied in Phosphate Buffered Saline (without Mg2+ and Ca2+), pH 7.4, with 150mM NaCl, 0.02% Sodium Azide, and 50% Glycerol.

Storage

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Synonyms

CARD-containing IL-1 beta ICE-kinase, CARD-containing interleukin-1 beta-converting enzyme-associated kinase, CARDIAK, EC:2.7.10.2, Receptor-interacting protein 2, Receptor-interacting serine/threonine-protein kinase 2, RICK, RIP-2, RIP-like-interacting CLARP kinase, RIPK2, Tyrosine-protein kinase RIPK2

Isotype Controls

Suitable Secondaries

See all Anti-Rabbit IgG Secondaries →

Disclaimer

This product is for research use only. It is not intended for diagnostic or therapeutic use.

Scientific Validation DataValidation Data (3)

Enlarge Image

Western Blot - Anti-RIPK2 Antibody (A97287)

Western blot analysis of lysates from rat brain cells using Anti-RIPK2 Antibody. The right hand lane represents a negative control, where the antibody is blocked by the immunising peptide.

Enlarge Image

Immunohistochemistry - Anti-RIPK2 Antibody (A97287)

Immunohistochemical analysis of paraffin-embedded human brain tissue using Anti-RIPK2 Antibody. The right hand panel represents a negative control, where the antibody was pre-incubated with the immunising peptide.